Assembly Biosciences Q4 EPS $(1.74) Beats $(2.88) Estimate, Sales $7.16M

Assembly Biosciences, Inc. +2.22%

Assembly Biosciences, Inc.




Assembly Biosciences (NASDAQ: ASMB) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(2.88) by 39.58 percent. This is a 68.48 percent increase over losses of $(5.52) per share from the same period last year. The company reported $7.16 million in sales this quarter.
Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via